Annual report
7776.TEDINET S100XUKD
Period2025-01-01 → 2025-12-31
Filed2026-03-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 85
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥84m | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥193m | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥190m | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥126m | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥162m | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥1.0bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | −¥846m | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥848m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥710m | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥754m | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥887m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥866m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥858m | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income (owners) | −¥915m | 2021-01-01 → 2021-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.1bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥860m | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | −¥847m | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥760m | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥913m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.7bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.4bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.4bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥387m | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥270m | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.3bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.0bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.0bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-12-31v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-12-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥931m | at 2021-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥989m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥866m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥779m | 2023-01-01 → 2023-12-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥718m | 2022-01-01 → 2022-12-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥817m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥27m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥18m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥56m | 2023-01-01 → 2023-12-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥62m | 2022-01-01 → 2022-12-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥110m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥200m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥855m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.8bn | 2023-01-01 → 2023-12-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥882m | 2022-01-01 → 2022-12-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥397m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-31.82 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.72 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-29.43 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.31 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.18 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.08 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥35.37 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥62.1 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥68.08 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥47.26 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥56.44 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥57.43 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 76.0% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.9% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 35,557,719 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,666,419 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,459,019 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,422,619 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,759,419 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 36 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 38 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 35 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 30 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 44 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥229,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥218m |
| Cell Sheet Regenerative Medicinereportable segment | capex | 2025-01-01 → 2025-12-31 | ¥488,000 |
| Cell Sheet Regenerative Medicinereportable segment | employees | at 2025-12-31 | 20 pure |
| Cell Sheet Regenerative Medicinereportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥2m |
| Cell Sheet Regenerative Medicinereportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥2m |
| Cell Sheet Regenerative Medicinereportable segment | segment assets | at 2025-12-31 | ¥96m |
| Cell Sheet Regenerative Medicinereportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥723m |
| Laboratory Consumables And Equipmentreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥52m |
| Laboratory Consumables And Equipmentreportable segment | employees | at 2025-12-31 | 11 pure |
| Laboratory Consumables And Equipmentreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥82m |
| Laboratory Consumables And Equipmentreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥82m |
| Laboratory Consumables And Equipmentreportable segment | segment assets | at 2025-12-31 | ¥112m |
| Laboratory Consumables And Equipmentreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥105m |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥52m |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥84m |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥84m |
| —segment total | segment assets | at 2025-12-31 | ¥208m |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | −¥828m |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥16m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥2.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥230m |
| Cell Sheet Regenerative Medicinereportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥1m |
| Cell Sheet Regenerative Medicinereportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥1m |
| Cell Sheet Regenerative Medicinereportable segment | segment assets | at 2024-12-31 | ¥70m |
| Cell Sheet Regenerative Medicinereportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥596m |
| Laboratory Consumables And Equipmentreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥2m |
| Laboratory Consumables And Equipmentreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥192m |
| Laboratory Consumables And Equipmentreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥192m |
| Laboratory Consumables And Equipmentreportable segment | segment assets | at 2024-12-31 | ¥121m |
| Laboratory Consumables And Equipmentreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥21m |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥2m |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥193m |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥193m |
| —segment total | segment assets | at 2024-12-31 | ¥191m |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | −¥616m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 989
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes leases financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes equity in earnings losses of affiliates if equity method is applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Description of impairment loss not allocated to reportable segments | Prior1YearDuration_NonConsolidatedMember | Original text (Japanese)（注）「全社・消去」の金額は、セグメントに帰属しない全社資産に係る減損損失であります。 | |
| Description of impairment loss not allocated to reportable segments | CurrentYearDuration_NonConsolidatedMember | Original text (Japanese)（注）「全社・消去」の金額は、セグメントに帰属しない全社資産に係る減損損失であります。 | |
| Notes related parties financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of corporate bonds financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of borrowings financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus | |
| Other reference information (text) | FilingDateInstant | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |